Translating Science into Patient Impact with Kendra Rose

In this episode we are joined by Kendra Rose, Senior Vice President of BD&L at Bayer, who brings a blend of scientific depth and business acumen to the conversation. Her journey began with a passion for science which led her to pursue a Ph.D. in chemistry at Stanford University, before making a pivot to take her expertise into industry and joining Johnson & Johnson, then Novartis, and now Bayer.

Kendra reflects on the lessons that have shaped her career and offers advice for early-stage founders and scientists considering a similar path. The conversation covers everything from understanding consumer needs to the latest trends driving healthcare innovation. She also offers a look into the Bayer Co.Lab incubator ecosystem, sharing insights on what it takes to succeed in a competitive market.